**Core Concept**
Lupus anticoagulants (LA) are a type of antiphospholipid antibody that can cause a hypercoagulable state, leading to an increased risk of thrombosis and other clinical manifestations. They are named for their association with systemic lupus erythematosus (SLE), but can also be found in other autoimmune disorders and healthy individuals.

**Why the Correct Answer is Right**
Lupus anticoagulants work by inhibiting the phospholipid-dependent coagulation cascade, which can lead to a paradoxical increase in thrombin generation and a prothrombotic state. This is due to the binding of LA to phospholipid-binding proteins, such as beta-2 glycoprotein I (β2GPI), which is essential for the proper functioning of the coagulation cascade. The presence of LA can also lead to the activation of endothelial cells, platelets, and the complement system, further contributing to the development of thrombosis.

**Why Each Wrong Option is Incorrect**
**Option A:** Thrombocytopenia - LA can actually cause an increase in platelet count, not a decrease. This is due to the activation of platelets and the release of platelet-derived growth factor.
**Option B:** Vasculitis - LA are not typically associated with vasculitis, which is a different type of autoimmune vasculopathy.
**Option C:** Recurrent fetal loss - LA are actually a well-known cause of recurrent fetal loss, due to the increased risk of thrombosis and placental insufficiency.

**Clinical Pearl / High-Yield Fact**
Lupus anticoagulants are a classic example of a "paradoxical" antibody, as their name suggests an anticoagulant effect, but they actually increase the risk of thrombosis.

**Correct Answer: B. Vasculitis**